Warning: The NCBI web site requires JavaScript to function. more...
Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells.
Wright ME, Eng J, Sherman J, Hockenbery DM, Nelson PS, Galitski T, Aebersold R.
Genome Biol. 2003;5(1):R4. Epub 2003 Dec 23.
Related citations
Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease.
Lin B, White JT, Lu W, Xie T, Utleg AG, Yan X, Yi EC, Shannon P, Khrebtukova I, Lange PH, Goodlett DR, Zhou D, Vasicek TJ, Hood L.
Cancer Res. 2005 Apr 15;65(8):3081-91.
Quantitative profiling of LNCaP prostate cancer cells using isotope-coded affinity tags and mass spectrometry.
Meehan KL, Sadar MD.
Proteomics. 2004 Apr;4(4):1116-34.
Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
Pang B, Zhang H, Wang J, Chen WZ, Li SH, Shi QG, Liang RX, Xie BX, Wu RQ, Qian XL, Yu L, Li QM, Huang CF, Zhou JG.
Prostate. 2009 Aug 1;69(11):1176-87.
Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME, Nelson CC.
Cancer Res. 2004 Mar 15;64(6):2212-21.
Rap2 regulates androgen sensitivity in human prostate cancer cells.
Bigler D, Gioeli D, Conaway MR, Weber MJ, Theodorescu D.
Prostate. 2007 Oct 1;67(14):1590-9.
Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.
Rice L, Handayani R, Cui Y, Medrano T, Samedi V, Baker H, Szabo NJ, Rosser CJ, Goodison S, Shiverick KT.
J Nutr. 2007 Apr;137(4):964-72.
Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells.
Rowland JG, Robson JL, Simon WJ, Leung HY, Slabas AR.
Proteomics. 2007 Jan;7(1):47-63.
Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E, Merom O, Adi A, Karry R, Bidosee M, Ber R, Kaploun A, Stein A, Barkey RJ.
Mol Cell Endocrinol. 2004 May 31;220(1-2):109-23.
The program of androgen-responsive genes in neoplastic prostate epithelium.
Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin B.
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11890-5. Epub 2002 Aug 16.
Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells.
Chen M, Tanner M, Levine AC, Levina E, Ohouo P, Buttyan R.
Cell Cycle. 2009 Jan 1;8(1):149-57.
Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
Jackson KM, Frazier MC, Harris WB.
Anticancer Res. 2007 May-Jun;27(3B):1483-8.
ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.
Cai C, Hsieh CL, Omwancha J, Zheng Z, Chen SY, Baert JL, Shemshedini L.
Mol Endocrinol. 2007 Aug;21(8):1835-46. Epub 2007 May 15.
HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH.
Cancer Res. 2004 Dec 15;64(24):9185-92.
Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells.
Tu LC, Yan X, Hood L, Lin B.
Mol Cell Proteomics. 2007 Apr;6(4):575-88. Epub 2007 Jan 12.
Quantitative proteomic analysis of proteins released by neoplastic prostate epithelium.
Martin DB, Gifford DR, Wright ME, Keller A, Yi E, Goodlett DR, Aebersold R, Nelson PS.
Cancer Res. 2004 Jan 1;64(1):347-55.
GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, Pienta KJ, Lippman ME.
Prostate. 2006 Jun 1;66(8):886-94.
Sex steroid hormone metabolism and prostate cancer.
Soronen P, Laiti M, Törn S, Härkönen P, Patrikainen L, Li Y, Pulkka A, Kurkela R, Herrala A, Kaija H, Isomaa V, Vihko P.
J Steroid Biochem Mol Biol. 2004 Nov;92(4):281-6. Epub 2004 Dec 19. Review.
p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6.
Debes JD, Comuzzi B, Schmidt LJ, Dehm SM, Culig Z, Tindall DJ.
Cancer Res. 2005 Jul 1;65(13):5965-73.
Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
Agoulnik IU, Vaid A, Bingman WE 3rd, Erdeme H, Frolov A, Smith CL, Ayala G, Ittmann MM, Weigel NL.
Cancer Res. 2005 Sep 1;65(17):7959-67.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on